论文部分内容阅读
目的探讨抗幽门螺杆菌感染药物治疗消化性胃溃疡的临床效果。方法 40例消化性胃溃疡患者随机平分为2组,治疗组采用基于奥美拉唑的三联疗法治疗,对照组采用基于雷钡拉唑的三联疗法治疗。结果治疗后治疗组的有效率为90.0%,对照组为85.0%,2组有效率差异无统计学意义(P>0.05)。治疗前2组血清NO无明显差异(P>0.05)。治疗后2组NO都有明显上升(P<0.05),2组相比也无显著性差异(P>0.05)。结论抗幽门螺杆菌感染药物治疗消化性胃溃疡都能取得较好的效果,能减少血清NO含量,值得推广应用。
Objective To investigate the clinical efficacy of anti-Helicobacter pylori infection in the treatment of peptic ulcer. Methods Forty patients with peptic ulcer were randomly divided into two groups. The treatment group was treated with triple therapy based on omeprazole, while the control group was treated with triple therapy based on barium. Results After treatment, the effective rate was 90.0% in the treatment group and 85.0% in the control group. There was no significant difference in the effective rate between the two groups (P> 0.05). There was no significant difference in serum NO between the two groups before treatment (P> 0.05). The levels of NO in both groups after treatment were significantly increased (P <0.05), but there was no significant difference between the two groups (P> 0.05). Conclusion Anti-Helicobacter pylori infection in gastric ulcer patients can achieve better results, can reduce the serum NO content, it is worth promoting the application.